1/165
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Lesson 3: Use basic pharmacology terms such as drug mechanism of action, drug site of action, drug effects, therapeutic effects, side effects when describing drugs
Lesson 3: Describe the placebo effect and explain how it is relevant to clinical research
Lesson 3: Use principal pharmacokinetic factors to predict the bioavailability & time course of drug action (cont. in part II)
Lesson 3: Diagram different drug routes of administration and describe the advantages & disadvantages of each
Lesson 3: Design an animal experiment to determine how route of administration influences the addiction potential of a drug
Lesson 3: Illustrate how size, lipid solubility, and ionization influence drug absorption & distribution (also consider the blood-brain barrier)
Lesson 4: Use principal pharmacokinetic factors to predict the bioavailability & time course of drug action (cont. from part I)
Lesson 4: Describe depot binding and its influence on magnitude and duration of drug action
Lesson 4: Interpret graphs of drug clearance and describe the reasons for the kinetics
Lesson 4: Describe the two different phases of drug metabolism
Lesson 4: Predict how liver enzyme interactions can impact drug effects
Lesson 5: Define the main types of receptors and their function
Lesson 5: Explain drug-receptor interactions such as agonism, antagonism, and allosterism using illustrations that model affinity and efficacy
Lesson 5: Predict clinical implications of receptor upregulation and downregulation
Lesson 6: Understand dose-response curves as exhibited by:
Lesson 6: Designing an experiment to collect dose-response data
Lesson 6: Drawing and labeling a dose-response curve based on a description of receptor activity
Lesson 6: Interpreting a dose-response curve (or multiple dose-response curves) and explain receptor activity & drug-receptor interactions from the data presented
Lesson 6: Describing the difference between potency & efficacy and representing it graphically
Lesson 6: Calculate and interpret a therapeutic index
Lesson 7: List the neurotransmitters within the categories of monoamines and catecholamines. Explain why they are categorized this way.
Lesson 7: Diagram a catecholamine synapse and use it to describe the synthesis, storage, release, and degradation of catecholamines.
Lesson 7: Describe the steps of biosynthesis of each catecholamine—know the precursors & enzymes.
Lesson 7: Describe which factors can regulate the rate of synthesis of catecholamines.
Lesson 7: Describe how catecholamines are loaded into vesicles
Lesson 7: Describe how catecholamine signaling can be terminated
Lesson 7: Describe how drugs can affect each step in the synthesis, storage, release, and degradation process and how this gives rise to their behavioral effects.
Lesson 8: Know the different DA & NE receptor subtypes, their signaling pathways, and involvement in behavior
Lesson 8: Understand the mechanisms of action and predict the behavioral effects of drugs that target the DA & NE receptor subtypes
Lesson 9: Diagram a serotonin synapse and use it to describe the synthesis, storage, release, and degradation of serotonin
Lesson 9: Describe the steps of biosynthesis of serotonin—know the precursor & enzymes
Lesson 9: Describe which factors can regulate the rate of synthesis of serotonin
Lesson 9: Describe how serotonin is loaded into vesicles
Lesson 9: Describe how serotonin signaling can be terminated
Lesson 9: Know the different 5-HT receptor subtypes, their signaling pathways, and involvement in behavior.
Lesson 9: Understand the mechanisms of action and predict the behavioral effects of drugs that target the 5-HT receptor subtypes.
Lesson 10: Diagram the neuroanatomy and describe the function of monoamine pathways in the brain
Lesson 10: Discuss and compare the primary approaches neuroscientists use to study connectivity between brain regions
Lesson 10: Explain how proteins involved in synthesis, storage, release, re-uptake, and degradation of monoamines can be used as biomarkers
Lesson 12: Describe the localization and functions of acetylcholine
Lesson 12: Diagram a cholinergic synapse and use it to describe the synthesis, storage, release, and degradation of acetylcholine
Lesson 12: Describe the steps of biosynthesis of acetylcholine—know the precursor & enzymes
Lesson 12: Describe how acetylcholine is loaded into vesicles
Lesson 12: Describe how acetylcholine signaling can be terminated
Lesson 12: Describe how drugs can affect synthesis and degradation of acetylcholine and how this gives rise to their behavioral effects
Lesson 12: Describe the structure and signaling of both the ionotropic and metabotropic cholinergic receptors
Lesson 12: nAChRs have multiple functional states—describe the properties of each state, including whether agonist is bound or not
Lesson 12: Describe the interactions of both types of cholinergic receptors with other neurotransmitter systems—especially regarding changes in neurotransmitter release
Lesson 12: Understand the mechanisms of action and predict the behavioral effects of drugs that target nAChR subtypes & mAChR subtypes
Lesson 13: Diagram a glutamate synapse and use it to describe the synthesis, storage, release, and degradation of glutamate
Lesson 13: Describe the steps of biosynthesis of glutamate—know the precursor & enzymes
Lesson 13: Describe how glutamate is loaded into vesicles
Lesson 13: Describe how glutamate signaling can be terminated
Lesson 13: Describe how drugs can affect synthesis and degradation of glutamate and how this gives rise to their behavioral effects.
Lesson 13: Describe the functions of glutamate in the nervous system
Lesson 13: Know the different ionotropic & metabotropic glutamate receptor subtypes, their signaling pathways, and involvement in behavior.
Lesson 13: Describe the properties of the NMDA receptor specifically with regard to long-term potentiation
Lesson 13: Predict behavioral effects of drugs that target ionotropic glutamate receptor subtypes based on their mechanisms of action.
Lesson 13: Describe the effects and primary mechanism of action for PCP & ketamine. How is this mechanism related theoretically to the neurochemical basis of schizophrenia?
Lesson 13: Describe the firing pattern & structure of glutamate -> lesson 15
Lesson 14: Diagram a GABA synapse and use it to describe the synthesis, storage, release, and degradation of GABA
Lesson 14: Describe the steps of biosynthesis of GABA—know the precursor & enzymes
Lesson 14: Describe how GABA is loaded into vesicles
Lesson 14: Describe how GABA signaling can be terminated
Lesson 14: Describe how drugs can affect synthesis and degradation of GABA and how this gives rise to their behavioral effects.
Lesson 14: Describe the functions of GABA in the nervous system
Lesson 14: Know the different GABA receptor subtypes, their signaling pathways, and involvement in behavior
Lesson 14: Describe the properties of the GABA-A receptor specifically with regards to allosteric modulation
Lesson 14: Understand the mechanisms of action and predict the behavioral effects of drugs that target the GABA receptor subtypes
Lesson 15: Identify and label the major phases of a neuronal action potential and explain, at a conceptual level, how ion movement across the membrane generates these phases.
Lesson 15: Explain how differences in neuronal morphology support distinct functional roles in excitation and inhibition within neural circuits.
Lesson 15: Compare electrophysiological firing patterns across neuron types and use these patterns to distinguish between likely glutamatergic (excitatory) and GABAergic (inhibitory) neurons.
Lesson 15: Predict how changes in morphology due to chronic stress or depression could affect neurotransmission
Lesson 16: Diagram the components of the reward circuit.
Lesson 16: Integrate the reward circuit with neurochemical information about how all drugs of abuse we’ll cover will specifically interact with it
Lesson 16: Explain incentive salience and incentive sensitization
Lesson 16: Provide evidence for why dopamine is not the “pleasure neurotransmitter”
Lesson 16: Identify neuroadaptations involved in addiction
Lesson 16: Discuss Koob & LeMoal's application of the opponent-process model of motivation and the process of allostasis in addiction
Lesson 17: Categorize the drugs listed in the schedule at the end of the syllabus into the five drug classifications in the Schedule of Controlled Substances
Lesson 17: Connect the criteria for diagnosing someone with substance use disorder (DSM-5) with what you've learned about reward & motivation pathways
Lesson 17: Define the terms relapse and remission. Define abstinence syndrome--what is the role of craving in relapse?
Lesson 17: Design an animal experiment to determine how route of administration influences the addiction potential of a drug
Lesson 17: Describe the three stages associated with substance use that can lead to a downward spiral resulting in addiction
Lesson 18: Describe alcohol pharmacokinetics (including absorption, distribution, and metabolism)
Lesson 18: Understand the effects of alcohol on the NMDARs, GABAARs, and CRF and the impact on behavior
Lesson 18: Understand how the concepts of tolerance & withdrawal apply to alcohol use
Lesson 18: Describe the animal models of alcohol self-administration
Lesson 18: Understand how stress and other risk factors increase vulnerability to alcohol use disorder
Lesson 18: Compare and contrast treatments for alcohol use disorder
Lesson 19: Describe opioid effects on the brain
Lesson 19: Name the four opioid receptor subtypes, match them with their endogenous ligands, and describe their functions.
Lesson 19: Illustrate how opioid receptors work and be able to predict the types of cellular inhibition that may arise when activated
Lesson 19: Describe the neurochemical basis of opioid reinforcement
Lesson 19: Predict what withdrawal from opioids would look like behaviorally and neurochemically
Lesson 19: Apply their knowledge to identify potential treatments for opioid withdrawal
Lesson 19: Compare and contrast treatments for opioid use disorder.
Lesson 20: Compare the behavioral CNS-related effects of cocaine & amphetamines
Lesson 20: Compare and contrast the typical routes of administration for cocaine & amphetamines as well as the pharmacokinetics (including absorption, distribution, and metabolism)
Lesson 20: Compare and contrast cocaine & methamphetamine mechanisms of action